| Issue Date | Title | Author(s) |
| 16-Jun-2021 | A suite of activity-based probes to dissect the KLK activome in drug-resistant prostate cancer | Lovell, S; Zhang, L; Kryza, T; Neodo, A; Bock, N, et al |
| 1-Jul-2017 | CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial | Stebbing, J; Baranau, Y; Baryash, V; Manikhas, A; Moiseyenko, V, et al |
| 25-Jun-2018 | Cyclin d1 depletion interferes with cancer oxidative balance and sensitizes cancer cells to senescence | Laphanuwat, P; Likasitwatanakul, P; Sittithumcharee, G; Thaphaengphan, A; Chomanee, N, et al |
| 27-Sep-2016 | Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer | Li, H; Stokes, W; Chater, E; Roy, R; De Bruin, E, et al |
| 1-Jan-2017 | Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high CTC counts | Shaw, JA; Guttery, DS; Hills, A; Fernandez-Garcia, D; Page, K, et al |
| 17-Jan-2012 | The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy | Payne, RE; Hava, NL; Page, K; Blighe, K; Ward, B, et al |
| 21-Mar-2016 | Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer | Landy, J; Ronde, E; English, N; Clark, SK; Hart, AL, et al |